相关实验视频

Updated: Jun 19, 2026

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

治疗前死亡风险预测模型在患有多聚炎/皮质炎相关的间歇性肺病患者中

Xianhua Gui¹, Wangzhong Li², Hanyi Jiang¹

¹Department of Respiratory Medicine, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, China.

|April 25, 2024

概括

一个新的模型预测了多聚炎/皮质炎相关的间歇性肺病 (PM/DM-ILD) 患者的死亡风险. 该工具使用简单的临床数据来帮助决策,以获得更好的患者结果.

科学领域:

类风湿病学类风湿病学
肺部病理学肺部病理学
医疗信息学医疗信息学

背景情况:

由于疾病进展的多变性,与多质神经炎/皮质神经炎相关的间歇性肺病 (PM/DM-ILD) 对风险预测具有挑战性.
准确的死亡风险评估对于有效管理PM/DM-ILD患者至关重要.

研究的目的:

开发和验证一个可靠的死亡风险预测模型,用于诊断为PM/DM-ILD的患者.
确定用于预测PM/DM-ILD的死亡率的关键临床和实验室指标.

主要方法:

一项涉及418名PM/DM-ILD患者的预后研究,从2016年至2021年.
使用最小绝对收缩和选择操作员 (LASSO) 逻辑回归来识别预测性实验室标记.
开发了一种综合模型,将实验室风险评分与临床因素相结合,用于死亡率预测.

主要成果:

确定了四个关键的实验室指标:C反应蛋白,乳酸脱酶,CD3+CD4+T细胞计数和PO2/FiO2比率.
最终的模型,包括年龄,关节痛,抗MDA5状态,CT模式和实验室得分,显示出强大的预测性能 (AUROC 0.869).
该模型有效地将患者分为三个不同的风险组,死亡率各不相同.

结论:

成功开发了一种基于证据的,经验证的PM/DM-ILD的死亡风险预测模型.
该模型采用可访问的临床变量,促进知情的临床决策和预后.
该工具为评估和管理PM/DM-ILD患者风险提供了实际实用性.

关键词:

这是自身免疫力.皮肤质神经炎 (dermatomyositis) 是一种这是一种多质神经炎.有关风险因素的风险因素.

更多相关视频

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

相关概念视频

Flail Chest-II

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...